Patents
Patents for C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
02/2005
02/17/2005US20050038085 Substituted benzimidazole antiviral agents
02/10/2005US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases
02/10/2005US20050032772 Compounds useful as reversible inhibitors of cysteine proteases
02/03/2005US20050025992 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
02/02/2005CN1573578A Electrophotographic organophotoreceptors with novel charge transport compounds
02/02/2005CN1573577A Organophotoreceptors with azine-based compounds
01/2005
01/27/2005WO2004082606A3 Fused pyrrole compounds
01/26/2005EP1499898A2 Regulation of tnf-alpha
01/26/2005CN1569854A Process for microwave extraction of matrine
01/25/2005US6846839 Identifying indolinone compounds that inhibit growth factor stimulated cell proliferation by contacting cells with compounds and with selected growth factors and monitoring inhibitory effect
01/20/2005US20050014754 Anticancer agents; antiinflammatory agents; autoimmune disease
01/19/2005CN1185231C Meadowrueleaf corydalis general alkaloid and its prepn and application
01/12/2005EP1495023A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
01/06/2005US20050003230 cyclized; organic light-emitting diodes (OLED); eliminate drawbacks of Alq3 as emitter and a host material for dopants; narrower emission bands; broad spectral range; low driver voltages; high photometric efficiency (low power consumption); high luminance (emission intensity); high thermal stability
12/2004
12/29/2004EP1490361A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
12/28/2004US6835725 Cyanine dye containing heterocylic rings; satisfies light stability, favorable signal/noise rato, damage free application to the substrate material, use in the information layer in a write-once optical data carrier
12/28/2004US6835514 Hydrazone-based charge transport compounds
12/23/2004WO2004076411A3 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
12/15/2004EP1485369A1 Blue 3h-naphtho- 2,1-b]-pyran derivatives and use thereof
12/15/2004CN1554656A Yunnan tolal biological coronaridine and its salts and preparing method and use
12/08/2004EP1482937A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
12/02/2004WO2004104000A1 Tricyclic condensed ring compound and medical use thereof
12/01/2004EP1482378A1 Electrophotographic organophotoreceptors with charge transport compounds
12/01/2004CN1550916A Organophotoreceptor with charge transport material having an amino-substituted hydrazone group and an epoxy group
11/2004
11/24/2004CN1548437A Low temperature vacuum matrine extracting process
11/18/2004US20040229903 4-Oxoquinolizine antibacterial agent having 2-pyridone skeleton as partial structure
11/17/2004EP1477186A1 Antipruritics
11/10/2004CN1545741A Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
11/10/2004CN1545700A Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer
11/04/2004US20040219446 Organophotoreceptors with azine-based compounds
11/03/2004EP1473599A1 Organophotoreceptors with azine-based compounds
10/2004
10/27/2004EP1471387A2 Photosensitive composition and compound used thereof
10/27/2004CN1172933C Prepn of matrine ,oxymatrine and sophoxidine from flavescent sophora root
10/06/2004CN1534379A Photosensitive composition and new compound therefor
09/2004
09/30/2004WO2004082606A2 Fused pyrrole compounds
09/30/2004US20040191679 Photosensitive composition and novel compound used therefor
09/30/2004CA2517034A1 Fused pyrrole compounds
09/29/2004EP1461337A1 Pyrido[2,1-a]isoquinoline derivatives as dpp-iv inhibitors
09/29/2004EP1028961B1 Pleuromutilin derivatives as antimicrobials
09/22/2004EP1227096B1 4-oxoquinolizine antimicrobials having 2-pyridone skeletons as the partial structure
09/22/2004EP0914321B1 Indole derivatives for the treatment of osteoporosis
09/22/2004CN1531724A Optical data carrier containing heterocyclic azy dye as light-absorbing compound in information layer
09/15/2004CN1529884A 光记录介质 The optical recording medium
09/10/2004WO2004076411A2 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
09/10/2004CA2516705A1 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
09/09/2004US20040176595 Glucocorticoid receptor modulators
09/09/2004US20040176406 Pyrido [2,1-a] isoquinoline derivatives
09/08/2004CN1527996A Optical data store mediam comprising axially substituted cobalt phthalocyanine in the light-writable information layer
09/07/2004US6787540 Compounds useful as reversible inhibitors of cysteine proteases
09/01/2004EP1452534A1 Pleuromutlin derivatives as antimicrobials
09/01/2004CN1525968A Compositions for prevention or treatment of hepatopathy
09/01/2004CN1164588C Preparation of berberine and its salts
08/2004
08/26/2004US20040167336 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine
08/12/2004WO2004056821A3 Quinolizidine derivatives
08/12/2004US20040157145 Organophotoreceptor with novel charge transport compounds having an epoxy group
08/05/2004US20040151998 Hydrazone-bridged (N,N-disubstituted)arylamine derivatives
08/04/2004EP1443365A1 Organophotoreceptor with charge transport material having an amino-substituted hydrazone group and an epoxy group
07/2004
07/29/2004WO2004037213A3 Nuclear hormone receptor compounds, products and methods employing same
07/29/2004US20040147525 Antiinflammatory agents; analgesics; antiarthritic agents
07/29/2004US20040146438 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching
07/28/2004CN1516872A Optical data carrier that contains triazacyanine dye as light-absorbing compound in information layer
07/21/2004CN1515002A Optical data carrier whose information layer contains light-absorbing compound having a number of chromophoric centers
07/21/2004CN1513852A Plant extract and its application
07/15/2004US20040138230 Psychological and central nervous system disorders; alzheimer's disease; Huntington's disease
07/14/2004EP1437354A1 4-oxoquinolizine antimicrobials having 2-pyridone skeleton as partial structure
07/14/2004CN1513176A Optical data carrier that contains triazycyanine dye as light-absorbing compound in the information layer
07/14/2004CN1513175A Optical data carrier that contains merocyanine dye as light-absorbing compound in the information layer
07/14/2004CN1513174A Optical data carrier containing axially substituted co-phthalocynine in the information layer that can be written with light
07/14/2004CN1513173A Optical data carrier containing a cyclizable compound in the information layer
07/14/2004CN1513172A An optica data storage medium containing diaze hemicyanine dye as light-absorbing compound in infomration layer
07/14/2004CN1513171A Optical data carrier containing dye in the information layer as light-absorbing compound
07/08/2004WO2004056821A2 Quinolizidine derivatives
07/08/2004US20040131648 Nuclear hormone receptor compounds, products and methods employing same
07/07/2004CN1156474C Chiral isoquinoline compound with cardiac vascular activity and its synthesis process
06/2004
06/29/2004US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis
06/22/2004US6753333 Arginine salt forms of s-(-)-9- fluoro-6,7-dihydro 8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,5h-benzo(i,j)quinolizine-2 -carboxylic acid, a process for their preparation and pharmaceutical formulations which are
06/15/2004US6750224 Used to systemically and topically treat bacterial gram-positive, gram-negative and anaerobic infections, especially resistant mycobacterial infections and emerging nosocomial pathogen infections
06/15/2004US6749978 Electrophotographic organophotoreceptors with novel charge transport compounds
06/02/2004EP1423006A1 Agonists and antagonists of 5h 3?-like receptors of invertebrate s as pesticides
05/2004
05/26/2004EP1421634A2 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives
05/20/2004US20040094753 Photochromic compound exhibits absorption bands in two wavelength regions of 440 to 500 nm and 570 to 630 nm.
05/19/2004EP0947513B1 Tricyclic amine derivatives
05/18/2004US6737142 Optical data store comprising an axially substituted cobalt phthalocyanine in the light-writeable information layer
05/06/2004WO2004037213A2 Nuclear hormone receptor compounds, products and methods employing same
05/06/2004CA2500974A1 Nuclear hormone receptor compounds, products and methods employing same
05/04/2004US6730418 Quinoline derivatives and organic electroluminescent devices
04/2004
04/29/2004US20040082619 Pyridone derivatives having affinity for cannabinoid 2-type receptor
04/28/2004CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor
04/27/2004US6727261 Pyrido[2,1-A]Isoquinoline derivatives
04/27/2004US6726972 Optical data storage medium containing a diaza hemicyanine dye as the light-absorbing compound in the information layer
04/20/2004US6723850 Process for the synthesis of (1-H)-benzo[c]quinolizin-3-ones derivatives
04/15/2004US20040072802 Antiarthritic agents; antiulcer agents; bone disorders; antitumor agents; oral diseases
04/14/2004EP1073655B1 Pharmaceutically available protoberberine salts derivatives, and protoberberine derivatives and salts thereof
04/13/2004US6720319 Compounds useful as reversible inhibitors of cysteine proteases
04/08/2004WO2004014893A3 Antimicrobial aza-bicyclic derivates, their compositions and uses
04/07/2004CN1144804C Benzo[C] quinolizine derivatives and their use as 5 alpha-reductases inhibitors
04/01/2004WO2004026864A1 Heterocyclic substituted piperazines for the treatment of schizophrenia
04/01/2004US20040063948 Crystalline fluoroquinolone arginine salt form
04/01/2004CA2499326A1 Heterocyclic substituted piperazines for the treatment of schizophrenia
03/2004
03/31/2004CN1485326A Process for preparing berberine sulphate
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 22